Berlex Bonefos For Breast Cancer Bone Metastases Set For Cmte. Review Dec. 2
This article was originally published in The Pink Sheet Daily
Executive Summary
Berlex is seeking an indication for the bisphosphonate clodronate as adjuvant therapy of bone metastases in Stage II/III breast cancer patients. Dec. 1 review date confirmed for Inex/Enzon’s Marqibo (liposomal vincristine) and Ilex’ Clolar (clofarabine).